Charles Schwab’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.49B | Buy |
12,773,386
+962,341
| +8% | +$343M | 0.69% | 32 |
|
|
2025
Q4 | $3.87B | Sell |
11,811,045
-1,739,567
| -13% | -$552M | 0.6% | 33 |
|
|
2025
Q3 | $3.82B | Buy |
13,550,612
+656,935
| +5% | +$191M | 0.61% | 31 |
|
|
2025
Q2 | $3.6B | Buy |
12,893,677
+687,735
| +6% | +$195M | 0.62% | 34 |
|
|
2025
Q1 | $3.8B | Sell |
12,205,942
-999,662
| -8% | -$295M | 0.71% | 30 |
|
|
2024
Q4 | $3.44B | Buy |
13,205,604
+2,672,975
| +25% | +$793M | 0.63% | 31 |
|
|
2024
Q3 | $3.39B | Buy |
10,532,629
+251,876
| +2% | +$82.4M | 0.65% | 32 |
|
|
2024
Q2 | $3.21B | Sell |
10,280,753
-551,589
| -5% | -$162M | 0.61% | 34 |
|
|
2024
Q1 | $3.08B | Buy |
10,832,342
+439,232
| +4% | +$129M | 0.71% | 25 |
|
|
2023
Q4 | $2.99B | Sell |
10,393,110
-500,785
| -5% | -$136M | 0.76% | 22 |
|
|
2023
Q3 | $2.93B | Sell |
10,893,895
-347,963
| -3% | -$86.8M | 0.84% | 23 |
|
|
2023
Q2 | $2.5B | Buy |
11,241,858
+480,421
| +4% | +$111M | 0.71% | 27 |
|
|
2023
Q1 | $2.6B | Buy |
10,761,437
+1,474,151
| +16% | +$362M | 0.79% | 26 |
|
|
2022
Q4 | $2.44B | Buy |
9,287,286
+50,756
| +0.5% | +$13.6M | 0.79% | 23 |
|
|
2022
Q3 | $2.08B | Buy |
9,236,530
+287,899
| +3% | +$69.8M | 0.75% | 22 |
|
|
2022
Q2 | $2.18B | Buy |
8,948,631
+128,941
| +1% | +$31.6M | 0.76% | 23 |
|
|
2022
Q1 | $2.13B | Buy |
8,819,690
+94,565
| +1% | +$21.7M | 0.64% | 27 |
|
|
2021
Q4 | $1.96B | Buy |
8,725,125
+561,955
| +7% | +$119M | 0.58% | 26 |
|
|
2021
Q3 | $1.74B | Buy |
8,163,170
+921,133
| +13% | +$212M | 0.57% | 28 |
|
|
2021
Q2 | $1.77B | Buy |
7,242,037
+871,428
| +14% | +$214M | 0.59% | 27 |
|
|
2021
Q1 | $1.59B | Buy |
6,370,609
+3,591,016
| +129% | +$857M | 0.58% | 25 |
|
|
2020
Q4 | $639M | Buy |
2,779,593
+23,212
| +0.8% | +$5.35M | 0.25% | 78 |
|
|
2020
Q3 | $701M | Sell |
2,756,381
-44,454
| -2% | -$11M | 0.32% | 58 |
|
|
2020
Q2 | $661M | Sell |
2,800,835
-53,551
| -2% | -$12.2M | 0.32% | 57 |
|
|
2020
Q1 | $579M | Buy |
2,854,386
+49,496
| +2% | +$10.8M | 0.34% | 55 |
|
|
2019
Q4 | $676M | Sell |
2,804,890
-65,428
| -2% | -$14.4M | 0.36% | 45 |
|
|
2019
Q3 | $555M | Sell |
2,870,318
-127,397
| -4% | -$24.5M | 0.33% | 51 |
|
|
2019
Q2 | $552M | Sell |
2,997,715
-46,466
| -2% | -$8.32M | 0.34% | 51 |
|
|
2019
Q1 | $578M | Sell |
3,044,181
-50,639
| -2% | -$9.67M | 0.37% | 44 |
|
|
2018
Q4 | $602M | Sell |
3,094,820
-35,501
| -1% | -$6.93M | 0.46% | 38 |
|
|
2018
Q3 | $649M | Sell |
3,130,321
-76,921
| -2% | -$15.2M | 0.43% | 38 |
|
|
2018
Q2 | $592M | Buy |
3,207,242
+72,205
| +2% | +$12.8M | 0.43% | 38 |
|
|
2018
Q1 | $534M | Sell |
3,135,037
-169,303
| -5% | -$31.1M | 0.42% | 40 |
|
|
2017
Q4 | $575M | Buy |
3,304,340
+123,250
| +4% | +$21.8M | 0.46% | 37 |
|
|
2017
Q3 | $593M | Buy |
3,181,090
+218,495
| +7% | +$38.7M | 0.52% | 36 |
|
|
2017
Q2 | $510M | Buy |
2,962,595
+67,815
| +2% | +$11M | 0.48% | 37 |
|
|
2017
Q1 | $475M | Buy |
2,894,780
+45,403
| +2% | +$7.54M | 0.48% | 37 |
|
|
2016
Q4 | $417M | Buy |
2,849,377
+27,306
| +1% | +$4.11M | 0.46% | 38 |
|
|
2016
Q3 | $470M | Sell |
2,822,071
-67,809
| -2% | -$11.5M | 0.55% | 31 |
|
|
2016
Q2 | $440M | Sell |
2,889,880
-132,634
| -4% | -$20.6M | 0.55% | 31 |
|
|
2016
Q1 | $453M | Sell |
3,022,514
-224,505
| -7% | -$33.4M | 0.59% | 31 |
|
|
2015
Q4 | $527M | Buy |
3,247,019
+11,041
| +0.3% | +$1.74M | 0.71% | 23 |
|
|
2015
Q3 | $449M | Buy |
3,235,978
+126,358
| +4% | +$19.9M | 0.66% | 24 |
|
|
2015
Q2 | $478M | Buy |
3,109,620
+65,245
| +2% | +$10.5M | 0.66% | 23 |
|
|
2015
Q1 | $487M | Buy |
3,044,375
+247,816
| +9% | +$39M | 0.68% | 22 |
|
|
2014
Q4 | $445M | Buy |
2,796,559
+241,928
| +9% | +$37.7M | 0.67% | 24 |
|
|
2014
Q3 | $359M | Buy |
2,554,631
+110,558
| +5% | +$14.4M | 0.59% | 26 |
|
|
2014
Q2 | $289M | Buy |
2,444,073
+6,686
| +0.3% | +$774K | 0.49% | 33 |
|
|
2014
Q1 | $301M | Buy |
2,437,387
+77,496
| +3% | +$9.4M | 0.54% | 28 |
|
|
2013
Q4 | $269M | Sell |
2,359,891
-231,665
| -9% | -$26.4M | 0.51% | 31 |
|
|
2013
Q3 | $297M | Sell |
2,591,556
-26,257
| -1% | -$2.85M | 0.6% | 27 |
|
|
2013
Q2 | $255M | Buy |
+2,617,813
| New | +$272M | 0.57% | 29 |
|
Other funds holding AMGN
VCM
VPM
Charles Schwab's AMGN Position: Q1 2026 in Review
Charles Schwab increased its Amgen (AMGN) stake by 8.1% in Q1 2026, buying an estimated $343M and bringing the position to 12,773,386 shares worth $4.49B. The position accounts for 0.69% of the portfolio, ranked #32.
Charles Schwab first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Charles Schwab held 12,773,386 shares of Amgen worth $4.49B as of Q1 2026.
- Charles Schwab bought 962,341 Amgen shares in Q1 2026, an estimated $343M.
- Amgen made up 0.69% of Charles Schwab's portfolio in Q1 2026, its #32 holding.
- Charles Schwab first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.